Clinical Trials Browser

OTHER × Carcinoma × Drug Therapy × Clear all

NCT07408635 2026-02-13

IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung Cancer

Phase 2 Recruiting

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT02994069 2025-10-14

Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers

Phase 2 Active not recruiting

80 enrolled 11 charts

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT07135882 2025-08-22

PRIME-Lung

Phase 3 Not yet recruiting

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04747054 2024-10-26

PembroMetaRT

Phase 3 Recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, Neoplasm Metastasis

NCT05541146 2023-03-23

Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis

Phase 2 Unknown

GastrointestinalGynecologic

Carcinoma, Peritoneal Neoplasms, Stomach Neoplasms

NCT04124731 2019-10-11

Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE)

Phase 2 Unknown

Carcinoma, Carcinoma, Non-Small-Cell Lung